$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000122460820000032 Filed on August 07, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$1.014B	$979.8M
YoY Change	3.51%	-6.36%
Cost Of Revenue	$540.3M	$610.4M
YoY Change	-11.48%	-1.26%
Gross Profit	$473.9M	$369.4M
YoY Change	28.29%	-13.71%
Gross Profit Margin	46.73%	37.7%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$880.4M	$886.2M
YoY Change	-0.65%	1.28%
Operating Profit	$102.2M	$96.70M
YoY Change	5.69%	-7.11%
Interest Expense	$28.40M	$38.60M
YoY Change	-26.42%	2.39%
% of Operating Profit	27.79%	39.92%
Other Income/Expense, Net
YoY Change
Pretax Income	$105.4M	$47.70M
YoY Change	120.96%	-63.25%
Income Tax	$23.40M	$10.10M
% Of Pretax Income	22.2%	21.17%
Net Earnings	$82.00M	$37.60M
YoY Change	118.09%	-63.21%
Net Earnings / Revenue	8.09%	3.84%
Basic Earnings Per Share	$0.57	$0.24
Diluted Earnings Per Share	$0.57	$0.24
COMMON SHARES
Basic Shares Outstanding	143.4M shares	158.8M shares
Diluted Shares Outstanding	143.9M shares	159.7M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$557.9M	$607.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$61.00M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.18B	$24.68B
YoY Change	6.11%	-8.46%
Other Assets	$429.0M	$348.0M
YoY Change	23.28%	-28.25%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$33.98B	$32.72B
YoY Change	3.86%	0.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$3.785B	$3.787B
YoY Change	-0.05%	-4.85%
Other Long-Term Liabilities	$788.0M	$740.0M
YoY Change	6.49%	13.15%
Total Long-Term Liabilities	$4.573B	$4.527B
YoY Change	1.02%	-2.31%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.573B	$4.527B
Total Liabilities	$29.25B	$28.46B
YoY Change	2.76%	1.59%
SHAREHOLDERS EQUITY
Retained Earnings	$545.3M	$249.2M
YoY Change	118.82%	-65.92%
Common Stock	$2.666B	$2.905B
YoY Change	-8.23%	-3.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.731B	$4.252B
YoY Change
Total Liabilities & Shareholders Equity	$33.98B	$32.72B
YoY Change	3.86%	0.75%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	$82.00M	$37.60M
YoY Change	118.09%	-63.21%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$199.3M	$175.4M
YoY Change	13.63%	2.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$201.4M	-$83.40M
YoY Change	141.49%	-41.6%
Cash From Investing Activities	-$201.4M	-$83.40M
YoY Change	141.49%	-41.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.500M	-175.4M
YoY Change	-105.42%	1765.96%
NET CHANGE
Cash From Operating Activities	199.3M	175.4M
Cash From Investing Activities	-201.4M	-83.40M
Cash From Financing Activities	9.500M	-175.4M
Net Change In Cash	7.400M	-83.40M
YoY Change	-108.87%	-532.12%
FREE CASH FLOW
Cash From Operating Activities	$199.3M	$175.4M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q2	cno	Investments Held By Variable Interest Entities Allowance For Credit Loss InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss	27700000	USD
CY2019Q4	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1206300000	USD
CY2020Q2	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1223700000	USD
CY2019Q2	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	100000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	100000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	148084178	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141718570	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	148084178	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141718570	shares
CY2019Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	44200000	USD
CY2020Q2	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	68500000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	123000000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	255300000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	254100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	40000000	USD
CY2020Q2	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	4000000	USD
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-31792
	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3108137
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11825 N. Pennsylvania Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46032
	dei	City Area Code CityAreaCode	(317)
	dei	Local Phone Number LocalPhoneNumber	817-6100
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	141719305	shares
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22167900000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21295200000	USD
CY2020Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	60500000	USD
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	44100000	USD
CY2020Q2	us-gaap	Notes Receivable Net NotesReceivableNet	1459900000	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1566100000	USD
CY2020Q2	us-gaap	Policy Loans Receivable PolicyLoansReceivable	124300000	USD
CY2019Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	124500000	USD
CY2020Q2	us-gaap	Trading Securities Debt TradingSecuritiesDebt	240600000	USD
CY2019Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	243900000	USD
CY2020Q2	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1137400000	USD
CY2019Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1188600000	USD
CY2020Q2	us-gaap	Other Investments OtherInvestments	993800000	USD
CY2019Q4	us-gaap	Other Investments OtherInvestments	1118500000	USD
CY2020Q2	us-gaap	Investments Investments	26184400000	USD
CY2019Q4	us-gaap	Investments Investments	25580900000	USD
CY2019Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	580000000.0	USD
CY2020Q2	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	36800000	USD
CY2020Q2	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	521100000	USD
CY2019Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	74700000	USD
CY2020Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	205300000	USD
CY2019Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	205900000	USD
CY2020Q2	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	263400000	USD
CY2019Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	275400000	USD
CY2020Q2	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1120900000	USD
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1215500000	USD
CY2020Q2	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4712600000	USD
CY2019Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4785700000	USD
CY2020Q2	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	428800000	USD
CY2019Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	432600000	USD
CY2020Q2	us-gaap	Separate Account Assets SeparateAccountAssets	3700000	USD
CY2019Q4	us-gaap	Separate Account Assets SeparateAccountAssets	4200000	USD
CY2020Q2	us-gaap	Other Assets OtherAssets	502500000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	476000000.0	USD
CY2020Q2	us-gaap	Assets Assets	33979500000	USD
CY2019Q4	us-gaap	Assets Assets	33630900000	USD
CY2020Q2	us-gaap	Policyholder Funds PolicyholderFunds	12171300000	USD
CY2019Q4	us-gaap	Policyholder Funds PolicyholderFunds	12132300000	USD
CY2020Q2	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11767500000	USD
CY2019Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11498500000	USD
CY2020Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	488600000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	522300000	USD
CY2020Q2	us-gaap	Unearned Premiums UnearnedPremiums	243600000	USD
CY2019Q4	us-gaap	Unearned Premiums UnearnedPremiums	260500000	USD
CY2020Q2	us-gaap	Separate Accounts Liability SeparateAccountsLiability	3700000	USD
CY2019Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4200000	USD
CY2020Q2	us-gaap	Other Liabilities OtherLiabilities	788300000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	750200000	USD
CY2020Q2	cno	Investment Borrowings InvestmentBorrowings	1643400000	USD
CY2019Q4	cno	Investment Borrowings InvestmentBorrowings	1644300000	USD
CY2020Q2	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1152200000	USD
CY2019Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1152500000	USD
CY2020Q2	us-gaap	Notes Payable NotesPayable	989700000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	989100000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	29248300000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	28953900000	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	1400000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1500000	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2664300000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2767300000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1520200000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	28400000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	38600000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1372500000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	545300000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	535700000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	4731200000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000000.0	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33979500000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33630900000	USD
CY2020Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	625300000	USD
CY2019Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	618300000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1254000000.0	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1237600000	USD
CY2020Q2	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	231700000	USD
CY2019Q2	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	284900000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	512000000.0	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	553700000	USD
CY2020Q2	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	87100000	USD
CY2019Q2	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	49600000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	-23600000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	136600000	USD
CY2020Q2	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	27900000	USD
CY2019Q2	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	5300000	USD
	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	-32200000	USD
	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	23600000	USD
CY2020Q2	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	15900000	USD
CY2019Q2	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	0	USD
	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-39500000	USD
	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-2200000	USD
CY2020Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	43800000	USD
CY2019Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	5300000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-71700000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	21400000	USD
CY2020Q2	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	26300000	USD
CY2019Q2	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	21700000	USD
	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	60700000	USD
	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	53500000	USD
CY2020Q2	us-gaap	Revenues Revenues	1014200000	USD
CY2019Q2	us-gaap	Revenues Revenues	979800000	USD
	us-gaap	Revenues Revenues	1731400000	USD
	us-gaap	Revenues Revenues	2002800000	USD
CY2020Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	540300000	USD
CY2019Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	610400000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1031100000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1233900000	USD
	us-gaap	Interest Expense InterestExpense	61800000	USD
	us-gaap	Interest Expense InterestExpense	79600000	USD
CY2020Q2	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	88500000	USD
CY2019Q2	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	46200000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	138700000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	104400000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	251600000	USD
CY2019Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	229600000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	465400000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	464300000	USD
CY2020Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	908800000	USD
CY2019Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	932100000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1697000000.0	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1889500000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	105400000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	47700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	34400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	113300000	USD
CY2020Q2	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	23400000	USD
CY2019Q2	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	10100000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	7600000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	23900000	USD
CY2020Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2019Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34000000.0	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	82000000.0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	37600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	89400000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143421000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158816000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144625000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159882000	shares
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	147700000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143941000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159735000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145269000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160962000	shares
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	82000000.0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	37600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	89400000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1656200000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	681300000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	330800000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1371500000	USD
CY2020Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	131000000.0	USD
CY2019Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	66200000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-5300000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	116700000	USD
CY2020Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-330500000	USD
CY2019Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-45000000.0	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-195000000.0	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-76500000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	15900000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4000000.0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-49700000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	2900000	USD
CY2020Q2	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	300000	USD
CY2019Q2	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	200000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-3100000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	400000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1179100000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	566300000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	187700000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1175800000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	254100000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	123000000.0	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	40000000.0	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	255300000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	925000000.0	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	443300000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	920500000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1007000000.0	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	480900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	208500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1009900000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	3837900000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	37600000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	443300000	USD
CY2019Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	55000000.0	USD
CY2019Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	17600000	USD
CY2019Q2	cno	Stock Based Compensation StockBasedCompensation	6000000.0	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4252200000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3765800000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	82000000.0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	925000000.0	USD
CY2020Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	30000000.0	USD
CY2020Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	17400000	USD
CY2020Q2	cno	Stock Based Compensation StockBasedCompensation	5800000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	4731200000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3370900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	89400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	920400000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	100000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	102000000.0	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33700000	USD
	cno	Stock Based Compensation StockBasedCompensation	10200000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4252200000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000000.0	USD
	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	147700000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	113000000.0	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33400000	USD
	cno	Stock Based Compensation StockBasedCompensation	9900000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	4731200000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1151200000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1151500000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	554400000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	559400000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	60700000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	53500000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	808200000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	819500000	USD
	us-gaap	Interest Paid Net InterestPaidNet	63900000	USD
	us-gaap	Interest Paid Net InterestPaidNet	79600000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	132400000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	143000000.0	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	431800000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	407900000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5000000.0	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	325000000.0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	317700000	USD
	cno	Sales Of Investments SalesOfInvestments	1011100000	USD
	cno	Sales Of Investments SalesOfInvestments	2463400000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	912500000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1094600000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	2296600000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	3675200000	USD
	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	9600000	USD
	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-8100000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	16200000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	84200000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-379600000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-209500000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	494200000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	425000000.0	USD
	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	0	USD
	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	6100000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000.0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3600000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	118100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	103800000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	33600000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	33800000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	762800000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	873800000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	654300000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	689500000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	65300000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	346800000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	66200000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	269700000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	347400000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	1100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-42200000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-156900000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-96800000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48700000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	654700000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	656600000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	557900000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	607900000	USD
	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	1100000	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	2095300000	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	2520600000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	0	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	-43700000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	0	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-11300000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-18900000	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-335800000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-227900000	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-189000000.0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-96500000	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-420600000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-380600000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1520200000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1372500000	USD
CY2020Q2	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-9300000	USD
CY2020Q2	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-132200000	USD
CY2020Q2	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-189000000.0	USD
CY2020Q2	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	71800000	USD
CY2019Q4	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-12200000	USD
CY2019Q4	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-26800000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-96500000	USD
CY2019Q4	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	29400000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	329800000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	336100000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1086600000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1133900000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1456300000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1561100000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11189800000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	13411700000	USD
CY2020Q2	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	14062500000	USD
CY2020Q2	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	16442800000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5579100000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5725100000	USD
CY2020Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19641600000	USD
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22167900000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	282200000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	286000000.0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1082200000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1130800000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1376600000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1481700000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10908600000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12583700000	USD
CY2019Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	13649600000	USD
CY2019Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	15482200000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5529900000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5813000000.0	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19179500000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21295200000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2309300000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	114700000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	239900000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10100000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	2549200000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	124800000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1262800000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	11400000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	341200000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	9700000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	1604000000.0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	21100000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	19900000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	4500000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-13100000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	500000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	0	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery	0	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	10800000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	2100000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	23700000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-14200000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	800000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	0	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery	0	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	10800000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8300000	USD
CY2020Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3300000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11600000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6700000	USD
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4900000	USD
	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11600000	USD
CY2020Q2	cno	Other Investments Allowance For Credit Loss Period Increase Decrease OtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	6700000	USD
CY2019Q2	cno	Other Investments Allowance For Credit Loss Period Increase Decrease OtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	0	USD
	cno	Other Investments Allowance For Credit Loss Period Increase Decrease OtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-22800000	USD
	cno	Other Investments Allowance For Credit Loss Period Increase Decrease OtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	0	USD
CY2020Q2	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
CY2019Q2	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-5100000	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-5100000	USD
CY2020Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	43800000	USD
CY2019Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	5300000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-71700000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	21400000	USD
	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-7600000	USD
CY2020Q2	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	9900000	USD
	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	17900000	USD
	us-gaap	Increase Decrease In Debt Securities Trading IncreaseDecreaseInDebtSecuritiesTrading	-6600000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-71700000	USD
	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-39500000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	21400000	USD
	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-2200000	USD
	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	402400000	USD
	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	877400000	USD
	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-2200000	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	200000	USD
CY2018Q4	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	200000	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment	0	USD
	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment	0	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Securities Sold OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold	0	USD
	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Securities Sold OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold	0	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Change In Status OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsChangeInStatus	0	USD
	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Change In Status OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsChangeInStatus	0	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows	0	USD
	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows	0	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	200000	USD
CY2019Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	200000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	82000000.0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	37600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	89400000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143421000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158816000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144625000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159882000	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	520000	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	919000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	644000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1080000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143941000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159735000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145269000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160962000	shares
CY2020Q1	cno	Numberof Product Lines NumberofProductLines	4	product_line
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q2	cno	Segment Revenues SegmentRevenues	956900000	USD
CY2019Q2	cno	Segment Revenues SegmentRevenues	954600000	USD
	cno	Segment Revenues SegmentRevenues	1774200000	USD
	cno	Segment Revenues SegmentRevenues	1938600000	USD
CY2020Q2	cno	Segment Expenses SegmentExpenses	854700000	USD
CY2019Q2	cno	Segment Expenses SegmentExpenses	857900000	USD
	cno	Segment Expenses SegmentExpenses	1566500000	USD
	cno	Segment Expenses SegmentExpenses	1758500000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	102200000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	96700000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	207700000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	180100000	USD
CY2020Q2	cno	Income Tax Benefit On Operating Income Loss IncomeTaxBenefitOnOperatingIncomeLoss	22800000	USD
CY2019Q2	cno	Income Tax Benefit On Operating Income Loss IncomeTaxBenefitOnOperatingIncomeLoss	20300000	USD
	cno	Income Tax Benefit On Operating Income Loss IncomeTaxBenefitOnOperatingIncomeLoss	44000000.0	USD
	cno	Income Tax Benefit On Operating Income Loss IncomeTaxBenefitOnOperatingIncomeLoss	37900000	USD
CY2020Q2	cno	Operating Income Loss Net Of Tax OperatingIncomeLossNetOfTax	79400000	USD
CY2019Q2	cno	Operating Income Loss Net Of Tax OperatingIncomeLossNetOfTax	76400000	USD
	cno	Operating Income Loss Net Of Tax OperatingIncomeLossNetOfTax	163700000	USD
	cno	Operating Income Loss Net Of Tax OperatingIncomeLossNetOfTax	142200000	USD
CY2020Q2	us-gaap	Revenues Revenues	1014200000	USD
CY2019Q2	us-gaap	Revenues Revenues	979800000	USD
	us-gaap	Revenues Revenues	1731400000	USD
	us-gaap	Revenues Revenues	2002800000	USD
CY2020Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	908800000	USD
CY2019Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	932100000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1697000000.0	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1889500000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	105400000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	47700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	34400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	113300000	USD
CY2020Q2	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	23400000	USD
CY2019Q2	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	10100000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	7600000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	23900000	USD
CY2020Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2019Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34000000.0	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	82000000.0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	37600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	89400000	USD
CY2020Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Net EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet	114000000	USD
CY2020Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	148000000.0	USD
CY2019Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-17500000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-71400000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-7500000	USD
CY2020Q2	us-gaap	Ceded Premiums Written CededPremiumsWritten	63600000	USD
CY2019Q2	us-gaap	Ceded Premiums Written CededPremiumsWritten	65400000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	125800000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	133300000	USD
CY2020Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	36200000	USD
CY2019Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	112300000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	142200000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	221000000.0	USD
CY2020Q2	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	5800000	USD
CY2019Q2	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	6400000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	11800000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	12900000	USD
CY2020Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	7200000	USD
CY2019Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	8900000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	15600000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	17800000	USD
CY2020Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11700000	USD
CY2019Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4100000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-51900000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9300000	USD
CY2020Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11700000	USD
CY2019Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000000.0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	59500000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14600000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23400000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23900000	USD
CY2020Q2	cno	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCARESAct	0	USD
CY2019Q2	cno	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCARESAct	0	USD
	cno	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCARESAct	-34000000.0	USD
	cno	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCARESAct	0	USD
CY2020Q2	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	23400000	USD
CY2019Q2	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	10100000	USD
	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	-26400000	USD
	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	23900000	USD
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.003
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.010
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.014
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
	cno	Effective Income Tax Rate Reconciliation Before Discrete Items Percent EffectiveIncomeTaxRateReconciliationBeforeDiscreteItemsPercent	0.221
	cno	Effective Income Tax Rate Reconciliation Before Discrete Items Percent EffectiveIncomeTaxRateReconciliationBeforeDiscreteItemsPercent	0.211
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.988
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.767
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.211
	cno	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCARESAct	-34000000.0	USD
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	419900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	532300000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	6900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	10300000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	351700000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	351300000	USD
CY2020Q2	cno	Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets	76800000	USD
CY2019Q4	cno	Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets	50300000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	50100000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	40400000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	905400000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	984600000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	10800000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	24400000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	139900000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	150100000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	420400000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	381200000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	571100000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	555700000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	334300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	428900000	USD
CY2020Q2	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	94500000	USD
CY2019Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	3700000	USD
CY2020Q2	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	428800000	USD
CY2019Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	432600000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	334300000	USD
CY2020Q2	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2020Q2	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
CY2020Q2	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0109
CY2020Q2	cno	Ownership Change Threshold Restricting Net Operating Loss Usage OwnershipChangeThresholdRestrictingNetOperatingLossUsage	0.50
CY2020Q2	cno	Nonoperating Loss Carryforwards NonoperatingLossCarryforwards	1999400000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	6900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	10300000	USD
CY2020Q2	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10300000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10900000	USD
CY2020Q2	us-gaap	Notes Payable NotesPayable	989700000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	989100000	USD
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	500000000.0	USD
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	500000000.0	USD
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	1000000000.0	USD
	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	113000000.0	USD
CY2020Q2	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	419300000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33400000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.23
CY2020Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.12
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	6500000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	14400000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	8700000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	2500000	USD
CY2020Q2	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	58500000	USD
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	60700000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21293100000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1559400000	USD
CY2020Q1	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1178700000	USD
CY2020Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	437500000	USD
CY2020Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4781700000	USD
CY2020Q1	us-gaap	Assets Assets	33613100000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	517900000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	4659200000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18443700000	USD
CY2019Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	630900000	USD
CY2019Q1	us-gaap	Assets Assets	31436700000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	193500000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	3367800000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 19, 2018, Melanie Cyganowski, as Equity Receiver for Platinum Partners Credit Opportunities Master Fund, LP ("PPCO") and other Platinum entities (the "PPCO Receiver") brought an action in the United States District Court for the Southern District of New York, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski v. Beechwood Re Ltd, et al.</span><span style="font-family:inherit;font-size:10pt;">, alleging, among other claims, fraud, aiding and abetting fraud, fraudulent transfer and violation of the Racketeer Influenced and Corrupt Organizations Act against numerous defendants, including Beechwood Re Ltd. ("BRe") and many of its affiliates and CNO Financial Group, Inc., Bankers Conseco Life Insurance Company ("BCLIC"), Washington National and 40\|86 Advisors, Inc. (collectively, the "CNO Parties"). The PPCO Receiver alleged that Platinum insiders conspired with BRe and its principals and affiliates in a massive fraudulent scheme to enrich the Platinum and BRe insiders to the detriment of Platinum investors and creditors. The PPCO Receiver alleged that CNO Financial Group, Inc., BCLIC, Washington National and 40\|86 Advisors, Inc. had liability for the fraudulent scheme of the Platinum and BRe insiders under a theory that they turned a blind eye to the fraudulent scheme due to their desire to transfer unprofitable legacy portfolios of long-term care insurance via the reinsurance transactions with BRe. On January 24, 2019, the court consolidated the PPCO Receiver action with </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> other cases (to which the CNO companies are not parties) before it for at least discovery purposes. On August 19, 2019, the court granted in their entirety CNO Financial Group, Inc.’s and 40\|86 Advisors, Inc.’s motions to dismiss the PPCO Receiver’s claims against them. The court granted in part and denied in part the motions to dismiss of BCLIC and Washington National, dismissing the PPCO Receiver’s claims for, among other things, fraud, aiding and abetting fraud, securities fraud and violation of the Racketeer Influenced and Corrupt Organizations Act, while denying BCLIC’s and Washington National’s motions to dismiss the PPCO Receiver’s fraudulent transfer and unjust enrichment claims. BCLIC and Washington National agreed with the PPCO Receiver to fully settle the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski</span><span style="font-family:inherit;font-size:10pt;"> case. Under the settlement, neither BCLIC nor Washington National will incur any liability or make any payment to anyone, but instead they were granted an unsecured claim against PPCO’s estate. The settlement agreement states that the PPCO Receiver’s decision to enter into the agreement was based in part on the CNO Parties’ credible arguments based on an expansive documentary record that the CNO Parties were not knowing participants in any fraud perpetrated by any of the Platinum funds or any of the Beechwood entities, but were instead purely victims of such fraud schemes. The settlement agreement was approved by the court, and the PPCO Receiver and all CNO Parties have filed a Stipulation of Dismissal with Prejudice that was accepted by the Court. The </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski</span><span style="font-family:inherit;font-size:10pt;"> case is thus completely concluded.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On April 9, 2019, BCLIC and Washington National commenced an action entitled</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association</span><span style="font-family:inherit;font-size:10pt;">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action"). In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with BRe, as well as for breaching its fiduciary duties to BCLIC and Washington National. The Court granted Wilmington’s motion to dismiss this litigation. BCLIC and Washington National are appealing the Court’s decision.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, the CNO Parties in Delaware Chancery Court. Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities. Plaintiffs contend that the Agera securities were fraudulently transferred to the Reinsurance Trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties. The CNO Parties are vigorously contesting the plaintiff’s claims. The CNO Parties had removed the case to the United States District Court for the District of Delaware but on April 6, 2020, the District Court granted the plaintiff's motion to remand the case back to the Delaware Chancery Court. The Plaintiff has filed an Amended Complaint and the CNO Parties will respond.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 28, 2019, BCLIC and Washington National commenced an action entitled Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action"). In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe. The Court granted KPMG’s motion to dismiss this litigation. BCLIC and Washington</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">National are appealing the Court’s decision.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions. Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers. We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities. The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>41</span></span><span style="font-family:inherit;font-size:10pt;"> states and the District of Columbia participated in this examination. In November 2018, we entered into a Global Resolution Agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds. Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions is comparing expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made.</span></div>
	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	41	state
	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	89400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	122000000.0	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-31400000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	27200000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	123100000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	329100000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	66000000.0	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-130900000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	132400000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	143000000.0	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	-71700000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	21400000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	10800000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	38000000.0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	325000000.0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	317700000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	10100000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	10400000	USD
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	6300000	USD
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	6300000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	12500000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	12400000	USD
CY2020Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	6400000	USD
CY2019Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	6100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	12700000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	12100000	USD
CY2020Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2300000	USD
CY2019Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10400000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5500000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14700000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60500000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	70100000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60500000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	70100000	USD
CY2020Q2	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1223700000	USD
CY2020Q2	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	1100000	USD
CY2020Q2	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	59700000	USD
CY2020Q2	cno	Variable Interest Entity Fixed Maturity Securities Allowance For Credit Loss VariableInterestEntityFixedMaturitySecuritiesAllowanceForCreditLoss	27700000	USD
CY2020Q2	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1137400000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-21300000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	3400000	USD
	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	17900000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	-3400000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	22200000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-14500000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	-9400000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	9600000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	267700000	USD
CY2020Q2	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	3	investment
CY2020Q2	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	518400000	USD
CY2020Q2	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	85900000	USD
	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.86
CY2020Q2	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.99
CY2020Q2	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.90

Files In Submission

Name	View Source	Status
0001224608-20-000032-index-headers.html	Edgar Link	pending
0001224608-20-000032-index.html	Edgar Link	pending
0001224608-20-000032.txt	Edgar Link	pending
0001224608-20-000032-xbrl.zip	Edgar Link	pending
cno-20200630.xsd	Edgar Link	pending
cno-20200630_cal.xml	Edgar Link	unprocessable
cno-20200630_def.xml	Edgar Link	unprocessable
cno-20200630_lab.xml	Edgar Link	unprocessable
cno-20200630_pre.xml	Edgar Link	unprocessable
cno0630202010-q.htm	Edgar Link	pending
cno0630202010-q_htm.xml	Edgar Link	completed
cno06302020ex311.htm	Edgar Link	pending
cno06302020ex312.htm	Edgar Link	pending
cno06302020ex321.htm	Edgar Link	pending
cno06302020ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgchart2020.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2020 Q2 Form 10-Q Financial Statement

#000122460820000032 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2020 Q2 Form 10-Q Financial Statement

#000122460820000032 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno